Acetylcholine (Ach) rechallenge is superior to the current standard in the detection of co-existing microvascular spasm patients with epicardial spasm, according to new research – suggesting a second challenge should be added to routine ACh testing to help identify co-existing endotypes and to evaluate individual treatment response.